The genetic variants p.R409Q (described in cancer) and p.N564D (described in cancer and vascular/overgrowth) had interaction energy that resulted in the former destabilizing the binding to PIK3CA and the latter stabilizing the binding significantly (Figure 4). Here, PIK3CA is linked to cancer.